The Activity of Members of the UDP-Glucuronosyltransferase Subfamilies UGT1A and UGT2B is Impaired in Patients with Liver Cirrhosis

被引:7
作者
Duthaler, Urs [1 ,2 ]
Bachmann, Fabio [1 ,2 ]
Ozbey, Agustos C. [3 ]
Umehara, Kenichi [3 ]
Parrott, Neil [3 ]
Fowler, Stephen [3 ]
Krahenbuhl, Stephan [1 ,2 ,4 ]
机构
[1] Univ Hosp Basel, Div Clin Pharmacol & Toxicol, CH-4031 Basel, Switzerland
[2] Univ Basel, Dept Biomed, Basel, Switzerland
[3] Roche Innovat Ctr Basel, Pharmaceut Sci, Roche Pharm Res & Early Dev, Basel, Switzerland
[4] Univ Hosp Basel, Dept Clin Res, Basel, Switzerland
关键词
DRUG-METABOLIZING-ENZYMES; ACETAMINOPHEN CLEARANCE; DOSE ADJUSTMENT; BASEL COCKTAIL; GLUCURONIDATION; PHARMACOKINETICS; DISPOSITION; DISEASE; IDENTIFICATION; TRANSPORTERS;
D O I
10.1007/s40262-023-01261-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and ObjectiveThe impact of liver cirrhosis on the activity of UDP-glucuronosyltransferases (UGTs) is currently not well characterized. We investigated the glucuronidation capacity and glucuronide accumulation in patients with liver cirrhosis.MethodsWe administered the Basel phenotyping cocktail (caffeine, efavirenz, flurbiprofen, omeprazole, metoprolol, midazolam) to patients with liver cirrhosis (n = 16 Child A, n = 15 Child B, n = 5 Child C) and n = 12 control subjects and obtained pharmacokinetic profiles of substrates and primary metabolites and their glucuronides.ResultsCaffeine and its metabolite paraxanthine were only slightly glucuronidated. The metabolic ratio (AUC(glucuronide)/AUC(parent), MR) was not affected for caffeine but decreased by 60% for paraxanthine glucuronide formation in Child C patients. Efavirenz was not glucuronidated whereas 8-hydroxyefavirenz was efficiently glucuronidated. The MR of 8-hydroxyefavirenz-glucuronide formation increased three-fold in Child C patients and was negatively correlated with the glomerular filtration rate. Flurbiprofen and omeprazole were not glucuronidated. 4-Hydroxyflurbiprofen and 5-hydroxyomeprazole were both glucuronidated but the corresponding MRs for glucuronide formation were not affected by liver cirrhosis. Metoprolol, but not alpha-hydroxymetoprolol, was glucuronidated, and the MR for metoprolol-glucuronide formation dropped by 60% in Child C patients. Both midazolam and its metabolite 1 '-hydroxymidazolam underwent glucuronidation, and the corresponding MRs for glucuronide formation dropped by approximately 80% in Child C patients. No relevant glucuronide accumulation occurred in patients with liver cirrhosis.ConclusionsDetailed analysis revealed that liver cirrhosis may affect the activity of UGTs of the UGT1A and UGT2B subfamilies according to liver function. Clinically significant glucuronide accumulation did not occur in the population investigated.
引用
收藏
页码:1141 / 1155
页数:15
相关论文
共 47 条
[1]  
ANDREASEN PB, 1979, ACTA MED SCAND, P99
[2]  
Arnaud Maurice J, 2011, Handb Exp Pharmacol, P33, DOI 10.1007/978-3-642-13443-2_3
[3]   Effect of deglucuronidation on the results of the Basel phenotyping cocktail [J].
Bachmann, Fabio ;
Duthaler, Urs ;
Krahenbuhl, Stephan .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (12) :4608-4618
[4]   Identification of human UGT isoforms responsible for glucuronidation of efavirenz and its three hydroxy metabolites [J].
Bae, S. K. ;
Jeong, Y-J. ;
Lee, C. ;
Liu, K-H. .
XENOBIOTICA, 2011, 41 (06) :437-444
[5]   Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7 - Identification of a critical aromatic amino acid residue at position 33 [J].
Barre, Lydia ;
Fournel-Gigleux, Sylvie ;
Finel, Moshe ;
Netter, Patrick ;
Magdalou, Jacques ;
Ouzzine, Mohamed .
FEBS JOURNAL, 2007, 274 (05) :1256-1264
[6]   Glucuronidation of the Antiretroviral Drug Efavirenz by UGT2B7 and an in Vitro Investigation of Drug-Drug Interaction with Zidovudine [J].
Belanger, Anne-Sophie ;
Caron, Patrick ;
Harvey, Mario ;
Zimmerman, Peter A. ;
Mehlotra, Rajeev K. ;
Guillemette, Chantal .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (09) :1793-1796
[7]   CombiCap: A novel drug formulation for the basel phenotyping cocktail [J].
Camblin, Marine ;
Berger, Benjamin ;
Haschke, Manuel ;
Krahenbahl, Stephan ;
Huwyler, Jorg ;
Puchkov, Maxim .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 512 (01) :253-261
[8]  
Conn H O, 1981, Hepatology, V1, P673, DOI 10.1002/hep.1840010617
[9]   HEPATIC EXTRACTION OF MORPHINE IS IMPAIRED IN CIRRHOSIS [J].
CROTTY, B ;
WATSON, KJR ;
DESMOND, PV ;
MASHFORD, ML ;
WOOD, LJ ;
COLMAN, J ;
DUDLEY, FJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (05) :501-506
[10]   Dose adjustment in patients with liver disease [J].
Delcò, F ;
Tchambaz, L ;
Schlienger, R ;
Drewe, J ;
Krähenbühl, S .
DRUG SAFETY, 2005, 28 (06) :529-545